Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

For most investors, wealth creation is not about chasing the next big opportunity — it’s about understanding time and the quiet power of compounding. Financial planners often describe compounding as ...

Class 7's Ganita Prakash Part 2 revolutionizes math learning by connecting modern concepts to India's rich mathematical heritage. Highlighting figures like Brahmagupta and Bhaskaracharya, it reveals ...

Some mathematical formulas can uncover patterns so precise they seem to predict the future—appearing in nature, economics, and even human behavior. Trump signs executive order to reclassify marijuana ...

We recently published 12 Best Healthcare Stocks to Buy Under $30. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the best healthcare stocks. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a ...

The company isn't the only developer of a drug for FAP, a rare genetic disease. A rival just reported that its own FAP treatment is advancing to late-stage testing. This was largely due to news from a ...

At the risk of sounding like a pessimist, it's entirely possible that Kevin Durant, who is gearing up for his 18th NBA season, will never be given his flowers as one of the most skilled players the ...

Donald Trump blinked, and his massive new trade war has been drastically scaled back. Or, maybe not? Perhaps he’s just tweaking the details during a partial 90-day pause, and he preps other, different ...